Deal Details

Isto Acquires NovaBone

---

Summary

About

Isto, a biologics company dedicated to advancing bone healing, helps patients heal faster. With a complete portfolio of autologous therapies, synthetic bone grafts and allograft tissue solutions, Isto’s products are used in more than 15,000 surgical procedures per month across 400+ hospitals and clinics in the United States. Isto is headquartered in Hopkinton, Massachusetts.

Keensight, one of the leading European Growth Buyout firms, is committed to supporting entrepreneurs as they implement their growth strategies. With over 25 years of experience and more than €8 billion of assets under management, Keensight’s team of seasoned professionals leverages their differentiated private equity experience to invest in profitably growing companies generating revenues in the range of €10 million to €400 million. Drawing on its expertise in the Technology and Healthcare sectors, Keensight identifies the best investment opportunities in Europe and works closely with the management teams providing capital, strategic guidance and operational support. Keensight operates in more than 90 countries across the globe with a presence in Paris, London, Boston and Singapore.

NovaBone, founded in 2002, developed the first bioactive synthetic bone graft offered to the orthopedic community and has long been at the forefront of bioactive glass bone graft devices. It has developed numerous formulations and delivery systems of its patented, bioactive technology platform that results in accelerated bone growth. In total, their exclusively formulated bone graft substitute has been used for the repair of osseous defects throughout the skeletal system for over two decades and used in over two million clinical applications with unparalleled success validating the safety and efficacy of NovaBone’s technology. NovaBone is headquartered in Alachua, Florida.

Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. It employs over 9,000 people in more than 20 countries, with major operations in the United Kingdom, Europe, the United States and Asia Pacific. Halma is listed on the London Stock Exchange and is a constituent of the FTSE 100 index. Halma is headquartered in Amersham, United Kingdom.

---